Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin
Status:
Unknown status
Trial end date:
2019-01-30
Target enrollment:
Participant gender:
Summary
The change of glycemic variation and insulin dose after adding SGLT2 inhibitor in type 2
diabetic patients treated with basal insulin was observed in a single center.
Phase:
Phase 4
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University